TLR4 and neoplasm: The use of a TLR4-deficient mouse tumor model, as well as in vitro experiments in which the S100A4 receptor was blocked in MDSCs, finally established that the activation of TLR4–ERK signaling by extracellular S100A4 is responsible for the resistance of MDSCs to intrinsic apoptosis induction.